Detalhe da pesquisa
1.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
N Engl J Med
; 385(23): 2123-2131, 2021 12 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34874631
2.
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
BMC Med
; 22(1): 199, 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38755585
3.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35901833
4.
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma.
Cancer Sci
; 113(8): 2849-2861, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35661486
5.
Who really benefits from intraperitoneal chemotherapy for advanced ovarian cancer? A treatment-free survival analysis of the AICE trial.
BJOG
; 129 Suppl 2: 32-39, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36485070
6.
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(4): 439-449, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33705695
7.
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.
Br J Cancer
; 121(5): 425-428, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31383985
8.
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.
Br J Cancer
; 119(1): 12-18, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29899395
9.
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.
Cell Physiol Biochem
; 47(5): 2088-2096, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29975922
10.
Hydrogen postconditioning promotes survival of rat retinal ganglion cells against ischemia/reperfusion injury through the PI3K/Akt pathway.
Biochem Biophys Res Commun
; 495(4): 2462-2468, 2018 01 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29288664
11.
Resection of metastatic ovarian cancer in the supragastric lesser sac in 10 steps.
Int J Gynecol Cancer
; 33(2): 308-309, 2023 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36253004
12.
Splenectomy via the posterolateral approach in ovarian cancer.
Int J Gynecol Cancer
; 33(8): 1320-1321, 2023 08 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37169393
13.
BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
Int J Cancer
; 140(9): 2051-2059, 2017 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28176296
14.
Difference in Practice Patterns in the Management of Endometrial Cancer: A Survey of the Members of 4 East Asian Gynecologic Oncology Groups.
Int J Gynecol Cancer
; 27(9): 1888-1894, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28953133
15.
Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.
Gynecol Obstet Invest
; 82(1): 30-38, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-26986489
16.
Secondary cytoreduction for relapsed ovarian cancer - Authors' reply.
Lancet Oncol
; 22(6): e233, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34087142
17.
Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
Tumour Biol
; 36(9): 6919-27, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25854172
18.
Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study.
BMC Cancer
; 15: 583, 2015 Aug 13.
Artigo
Inglês
| MEDLINE | ID: mdl-26268818
19.
Role of Transdiaphragmatic Thoracic Exploration in Bulky Stage IIIC Ovarian Cancer Patients Who Underwent Diaphragmatic Surgery.
Int J Gynecol Cancer
; 25(8): 1392-7, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26222485
20.
Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer.
Int J Gynecol Cancer
; 25(8): 1398-404, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26222486